Approval · Notice of Compliance 493 · 2002
PROPECIA: Notice of Compliance 493
Issued December 24, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 493
- Date
- December 24, 2002
- Company
- Merck Frosst Canada & Cie, Merck Frosst Canada & Co.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of five-year clinical data to product monograph
- Therapeutic class
- Type II 5 alpha-reductase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROPECIA | Not yet assigned | — |
Medicinal ingredients
- FINASTERIDE 1 MG per TAB